Ratio of phosphorylated Tau in position 396 and 404 in CSF could discriminate AD from other dementia; Identification by ELISA [161]Identification of phosphorylated biomarkers pTau181, pTau199 and pTau231 in CSF by immunoassays [162-167]. This evidence concerns the gene MAPT and dementia.